- Home
- DNLI vs BANF Comparison
DNLI vs BANF Comparison
Compare DNLI & BANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | BANF |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | 2260 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | DNLI | BANF |
|---|---|---|
| Price | $23.48 | $116.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 2 |
| Target Price | $34.33 | ★ $124.00 |
| AVG Volume (30 Days) | ★ 2.0M | 196.7K |
| Earning Date | 05-06-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.10 |
| Revenue Next Year | $408.85 | $3.92 |
| P/E Ratio | ★ N/A | $16.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.58 | $101.48 |
| 52 Week High | $27.30 | $138.15 |
Technical Indicators
Market Signals| Indicator | DNLI | BANF |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 55.71 |
| Support Level | $18.27 | $110.33 |
| Resistance Level | $27.30 | $122.05 |
| Average True Range (ATR) | 1.37 | 2.47 |
| MACD | -0.54 | 0.40 |
| Stochastic Oscillator | 27.69 | 56.11 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About BANF BancFirst Corporation
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Its Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.